Company · CIK 1404644
Neurogene Inc.
| CIK | 1404644 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | NY |
| Listed | NGNE (Nasdaq) |
| First annual or quarterly report | 2014-05-13 |
Offerings
9 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-286057 | 2025-03-24 | 2026-07-02 | 5 | |
| 333-283561 | 2024-12-02 | 2025-03-28 | 3 | |
| 333-264803 | 2022-05-09 | 2022-05-18 | 2 | |
| 333-251294 | 2020-12-11 | 2021-11-04 | 3 | |
| 333-223584 | 2018-03-12 | 2020-07-02 | 6 | |
| 333-215457 | 2017-01-06 | 2017-01-19 | 2 | |
| 333-208651 | 2015-12-21 | 2016-09-20 | 4 | |
| 333-203180 | 2015-04-01 | 2015-09-10 | 5 | |
| 333-193615 | 2014-01-28 | 2014-03-07 | 4 |
Filings
36| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-07-02 | 424B5Shelf takedown | 333-286057 | 0001628280-26-046666 |
| 2026-06-30 | 424B5Shelf takedown | 333-286057 | 0001628280-26-046237 |
| 2025-08-11 | 424B5Shelf takedown | 333-286057 | 0001628280-25-039623 |
| 2025-04-04 | EFFECTDeclared effective | 333-286057 | 9999999995-25-000988 |
| 2025-03-28 | EFFECTDeclared effective | 333-283561 | 9999999995-25-000829 |
| 2025-03-24 | S-3Shelf registered | 333-286057 | 0001628280-25-014521 |
| 2024-12-16 | EFFECTDeclared effective | 333-283561 | 9999999995-24-003791 |
| 2024-12-02 | S-1Registration filed | 333-283561 | 0001628280-24-049615 |
| 2023-11-13 | EFFECTDeclared effective | 333-274095 | 9999999995-23-003297 |
| 2022-05-18 | EFFECTDeclared effective | 333-264803 | 9999999995-22-001522 |
| 2022-05-09 | S-3Shelf registered | 333-264803 | 0001193125-22-145088 |
| 2021-11-04 | 424B5Shelf takedown | 333-251294 | 0001193125-21-320305 |
| 2020-12-21 | EFFECTDeclared effective | 333-251294 | 9999999995-20-003602 |
| 2020-12-11 | S-3Shelf registered | 333-251294 | 0001193125-20-315863 |
| 2020-07-02 | 424B5Shelf takedown | 333-223584 | 0001193125-20-186822 |
| 2020-07-01 | 424B5Shelf takedown | 333-223584 | 0001193125-20-185196 |
| 2019-12-18 | 424B5Shelf takedown | 333-223584 | 0001193125-19-317636 |
| 2019-12-17 | 424B5Shelf takedown | 333-223584 | 0001193125-19-316290 |
| 2018-04-06 | EFFECTDeclared effective | 333-223584 | 9999999995-18-000773 |
| 2018-03-12 | S-3Shelf registered | 333-223584 | 0001193125-18-079227 |
| 2017-01-19 | EFFECTDeclared effective | 333-215457 | 9999999995-17-000174 |
| 2017-01-06 | S-3Shelf registered | 333-215457 | 0001193125-17-004582 |
| 2016-09-20 | 424B5Shelf takedown | 333-208651 | 0001193125-16-714904 |
| 2016-09-19 | 424B5Shelf takedown | 333-208651 | 0001193125-16-713517 |
| 2016-01-26 | EFFECTDeclared effective | 333-208651 | 9999999995-16-003597 |
| 2015-12-21 | S-3Shelf registered | 333-208651 | 0001193125-15-408298 |
| 2015-09-10 | 424B5Shelf takedown | 333-203180 | 0001193125-15-316995 |
| 2015-09-08 | 424B5Shelf takedown | 333-203180 | 0001193125-15-314455 |
| 2015-04-09 | EFFECTDeclared effective | 333-203180 | 9999999995-15-000839 |
| 2015-04-09 | 424B5Shelf takedown | 333-203180 | 0001193125-15-124259 |
| 2015-04-01 | S-3Shelf registered | 333-203180 | 0001193125-15-116094 |
| 2014-03-07 | 424B4Final prospectus | 333-193615 | 0001193125-14-088912 |
| 2014-03-06 | EFFECTDeclared effective | 333-193615 | 9999999995-14-000604 |
| 2014-02-28 | S-1/AAmendment | 333-193615 | 0001193125-14-074419 |
| 2014-01-28 | S-1Registration filed | 333-193615 | 0001193125-14-024524 |
| 2013-11-18 | DRSDraft made public | 377-00373 | 0000950123-13-009948 |